PROMISE
  • Home
  • Our Team
  • Projects
  • Publications
  • Opportunities
  • Contact
Picture

PROgram on the Pharmacoepidemiology of Cardiovascular-Kidney-Metabolic DISEases


MISSION
 
The mission of the Program on the Pharmacoepidemiology of Cardiovascular-Kidney-Metabolic Diseases (PROMISE) is to advance the understanding of the treatments for cardio-kidney-metabolic diseases in clinical practice, in order to inform medical prescribing and improve patient care.

WHAT WE DO & WHO WE ARE

We study utilization, safety, effectiveness, and cost-effectiveness of treatment strategies among patients with
cardio-kidney-metabolic diseases in clinical practice, through the use of cutting-edge epidemiologic and statistical methods, leveraging one of the nation’s largest data repository of longitudinal healthcare data to conduct pharmacoepidemiologic research in cardio-kidney-metabolic diseases, including claims data for over 200 million lives, registries, and electronic health records, and innovative linkage of different databases. ​PROMISE includes a multidisciplinary team with expertise in pharmacoepidemiology, statistics, endocrinology, nephrology, cardiology, and obesity medicine, and trains the next generation of researchers in pharmacoepidemiology of cardio-kidney-metabolic diseases from around the world. 
Picture

Check us out at ADA's 85th Scientific Session.
Click here for the schedule. 


Picture

Click here to read our newest publication! 

Picture
Fellowship Opportunities 
Division of Pharmacoepidemiology & Pharmacoeconomics
Department of Medicine
Brigham & Women's Hospital and Harvard Medical School
1620 Tremont Street Suite 3030 Boston, MA 02120
Picture
  • Home
  • Our Team
  • Projects
  • Publications
  • Opportunities
  • Contact